{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:14:06Z","timestamp":1780564446480,"version":"3.54.1"},"reference-count":22,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2018,11,30]]},"DOI":"10.1536\/ihj.17-489","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T22:15:00Z","timestamp":1539123300000},"page":"1327-1332","source":"Crossref","is-referenced-by-count":29,"title":["RoPE Score as a Predictor of Recurrent Ischemic Events After Percutaneous Patent Foramen Ovale Closure"],"prefix":"10.1536","volume":"59","author":[{"given":"Lu\u00eds Almeida","family":"Morais","sequence":"first","affiliation":[{"name":"Cardiology University Centre, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia de","family":"Sousa","sequence":"additional","affiliation":[{"name":"Cardiology University Centre, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fiarresga","sequence":"additional","affiliation":[{"name":"Cardiology University Centre, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Diogo","family":"Martins","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Teresa","family":"Tim\u00f3teo","sequence":"additional","affiliation":[{"name":"Cardiology University Centre, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Viveiros","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Cardiology University Centre, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Soares","sequence":"additional","affiliation":[{"name":"Cardiology University Centre, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Agapito","sequence":"additional","affiliation":[{"name":"Cardiology University Centre, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Cruz","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Cardiology University Centre, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mozaffarian D, Benjamin EJ, Go AS, <i>et al<\/i>. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 2015; 131: e29-e322.","DOI":"10.1161\/CIR.0000000000000152"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117: 461-5.","DOI":"10.7326\/0003-4819-117-6-461"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mesa D, Franco M, Su\u00e1rez de Lezo J, <i>et al<\/i>. Prevalence of patent foramen ovale in young patients with cerebral ischemic accident of unknown origin. Rev Esp Cardiol 2003; 56: 662-8.","DOI":"10.1016\/S0300-8932(03)76936-X"},{"key":"4","unstructured":"4. Lechat P, Lascault G, Mas JL, <i>et al<\/i>. Prevalence of patent foramen ovale in young patients with ischemic cerebral complications. Arch Mal Coeur Vaiss 1989; 82: 847-52."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007; 357: 2262-8.","DOI":"10.1056\/NEJMoa071422"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Handke M, Harloff A, Bode C, Geibel A. Patent foramen ovale and cryptogenic stroke: a matter of age? Semin Thromb Hemost 2009; 35: 505-14.","DOI":"10.1055\/s-0029-1234146"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lechat P, Mas JL, Lascault G, <i>et al<\/i>. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-52.","DOI":"10.1056\/NEJM198805053181802"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pe\u00f1a JM, Kizer JR. Management of the stroke patient with patent foramen ovale: new insights and persistent questions in the wake of recent randomized trials. Curr Atheroscler Rep 2013; 15: 338.","DOI":"10.1007\/s11883-013-0338-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Carroll JD, Saver JL, Thaler DE, <i>et al<\/i>. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013; 368: 1092-100.","DOI":"10.1056\/NEJMoa1301440"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Furlan AJ, Reisman M, Massaro J, <i>et al<\/i>. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012; 366: 991-9.","DOI":"10.1056\/NEJMoa1009639"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Meier B, Kalesan B, Mattle HP, <i>et al<\/i>. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013; 368: 1083-91.","DOI":"10.1056\/NEJMoa1211716"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Agarwal S, Bajaj NS, Kumbhani DJ, Tuzcu EM, Kapadia SR. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv 2012; 5: 777-89.","DOI":"10.1016\/j.jcin.2012.02.021"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Khan AR, Bin Abdulhak AA, Sheikh MA, <i>et al<\/i>. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv 2013; 6: 1316-23.","DOI":"10.1016\/j.jcin.2013.08.001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Patti G, Pelliccia F, Gaudio C, Greco C. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale. Am J Cardiol 2015; 115: 837-43.","DOI":"10.1016\/j.amjcard.2014.12.051"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kwong JSW, Lam YY, Yu CM. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials. Int J Cardiol 2013; 168: 4132-8.","DOI":"10.1016\/j.ijcard.2013.07.077"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ntaios G, Papavasileiou V, Makaritsis K, Michel P. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Int J Cardiol 2013; 169: 101-5.","DOI":"10.1016\/j.ijcard.2013.08.058"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Thaler DE, Di Angelantonio E, Di Tullio MR, <i>et al<\/i>. The risk of paradoxical embolism (RoPE) study: initial description of the completed database. Int J Stroke 2013; 8: 612-9.","DOI":"10.1111\/j.1747-4949.2012.00843.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kent DM, Thaler DE. Is patent foramen ovale a modifiable risk factor for stroke recurrence? Stroke 2010; 41: S26-30.","DOI":"10.1161\/STROKEAHA.110.595140"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Saver JL, Carroll JD, Thaler DE, <i>et al<\/i>; RESPECT Investigators. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med 2017; 377: 1022-32.","DOI":"10.1056\/NEJMoa1610057"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kent DM, Thaler DE. The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Trials 2011; 12: 185.","DOI":"10.1186\/1745-6215-12-185"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Thaler DE, Ruthazer R, Weimar C, <i>et al<\/i>. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs. Neurology 2014; 83: 221-6.","DOI":"10.1212\/WNL.0000000000000589"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mas JL, Arquizan C, Lamy C, <i>et al<\/i>. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-6.","DOI":"10.1056\/NEJMoa011503"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/6\/59_17-489\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T05:00:30Z","timestamp":1543640430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/6\/59_17-489\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.17-489","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}